These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35666246)

  • 1. A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression.
    Cong Y; Shintani M; Imanari F; Osada N; Endo T
    OMICS; 2022 Jun; 26(6):339-347. PubMed ID: 35666246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
    Cong Y; Endo T
    OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular descriptor analysis of approved drugs using unsupervised learning for drug repurposing.
    Madugula SS; John L; Nagamani S; Gaur AS; Poroikov VV; Sastry GN
    Comput Biol Med; 2021 Nov; 138():104856. PubMed ID: 34555571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of artificial intelligence and machine learning in drug repurposing.
    Ghandikota SK; Jegga AG
    Prog Mol Biol Transl Sci; 2024; 205():171-211. PubMed ID: 38789178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.
    Esmail S; Danter W
    Stem Cells Transl Med; 2021 Feb; 10(2):239-250. PubMed ID: 32961040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Artificial Intelligence in COVID-19 drug repurposing.
    Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
    Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pharmacometric approach to evaluate drugs for potential repurposing as COVID-19 therapeutics.
    Wattanakul T; Chotsiri P; Scandale I; Hoglund RM; Tarning J
    Expert Rev Clin Pharmacol; 2022 Aug; 15(8):945-958. PubMed ID: 36017624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets.
    Mottini C; Napolitano F; Li Z; Gao X; Cardone L
    Semin Cancer Biol; 2021 Jan; 68():59-74. PubMed ID: 31562957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.
    Ahmed F; Soomro AM; Chethikkattuveli Salih AR; Samantasinghar A; Asif A; Kang IS; Choi KH
    Biomed Pharmacother; 2022 Sep; 153():113350. PubMed ID: 35777222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
    Ng YL; Salim CK; Chu JJH
    Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
    Das AB
    BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence, machine learning, and drug repurposing in cancer.
    Tanoli Z; Vähä-Koskela M; Aittokallio T
    Expert Opin Drug Discov; 2021 Sep; 16(9):977-989. PubMed ID: 33543671
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of potential pan-coronavirus therapies using a computational drug repurposing platform.
    Hwang W; Han N
    Methods; 2022 Jul; 203():214-225. PubMed ID: 34767922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1000CDS
    Duan Q; Reid SP; Clark NR; Wang Z; Fernandez NF; Rouillard AD; Readhead B; Tritsch SR; Hodos R; Hafner M; Niepel M; Sorger PK; Dudley JT; Bavari S; Panchal RG; Ma'ayan A
    NPJ Syst Biol Appl; 2016; 2():16015-. PubMed ID: 28413689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.